Perindopril arginine - Hypertension
You are here : Home > Formulary Search > Perindopril arginine - Hypertension
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Non Formulary
Formulations :
- Not Specified
Formulary Status :
Associated Icons :
Restrictions / Comments :
Important
NHS England guidance DO NOT ROUTINELY PRESCRIBE
Documentation
Guidelines (National)
Policy Statement
PAD Profile
ChemicalSubstance :
Perindopril arginine
Indication :
Hypertension
Group Name :
Keywords :
ACE inhibitors, high blood pressure, raised blood pressure, hypertension, heart failure, stable coronary artery disease, low value medicines, drugs of low clinical value, LVM, drugs of limited clinical value
Brand Names Include :
Coversyl Arginine
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
4
Other Indications
Below are listed other indications that Perindopril arginine is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Hypertension.
- Aliskiren
- Amlodipine
- Atenolol
- Azilsartan medoxomil
- Bendroflumethiazide
- Bisoprolol fumarate
- Candesartan cilexetil
- Captopril
- Carvedilol
- Celiprolol hydrochloride
- Chlortalidone
- Clonidine hydrochloride
- Co-tenidone (Atenolol/chlortalidone)
- Diltiazem hydrochloride
- Doxazosin mesilate
- Enalapril maleate
- Eprosartan
- Hydralazine hydrochloride
- Indapamide
- Irbesartan
- Irbesartan / Hydrochlorothiazide
- Lercanidipine hydrochloride
- Lisinopril
- Lisinopril / Hydrochlorothiazide
- Losartan potassium
- Metolazone
- Metoprolol tartrate
- Moxonidine
- Nebivolol
- Nicardipine hydrochloride
- Nifedipine
- Olmesartan medoxomil
- Perindopril erbumine
- Prazosin hydrochloride
- Propranolol hydrochloride
- Quinapril hydrochloride
- Ramipril
- Spironolactone
- Telmisartan
- Valsartan
- Valsartan with hydrochlorothiazide
Committee Recommendations (2)
At the Surrey and North-West Sussex Area Prescribing Committee (APC) held in June 2020, it was decided that all BLACK status drugs would have their review dates extended for 5 years without the need for a review.
If a clinician or provider wishes to change the traffic light status of any BLACK drug then they will need to submit a paper for change as per usual APC process.
The Prescribing Clinical Network does not recommend the use of perindopril arginine
Perindopril arginine will be considered BLACK on the traffic light system and prescribers should:
- NOT initiate perindopril arginine in any new patients
AND
- Switch any patients taking perindopril arginine to perindopril erbumine in line with NHS England guidance.
Perindopril arginine will be considered BLACK on the traffic light system and prescribers should:
- NOT initiate perindopril arginine in any new patients
AND
- Switch any patients taking perindopril arginine to perindopril erbumine in line with NHS England guidance.